Heart valve fix gets a High-Tech upgrade: Self-Centering catheter tested in humans
NCT ID NCT06412354
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a new device called VIVHEART EasyCross™ in 20 people undergoing transcatheter aortic valve replacement (TAVR). The device uses a basket-like tip to center itself in the artery, making it easier and quicker to guide a wire through the heart valve. The goal was to see if it is safe and can reduce procedure time.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AORTIC STENOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
San Raffaele Scientific Institute
Milan, 20132, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- AI ultrasound could unmask silent heart disease in seniors
- Heart valve fix without the hospital stay? trial tests Same-Day discharge
- Can a wearable monitor prevent heart emergencies after valve replacement?
- Could a common blood pressure pill protect the heart after valve replacement?
- Can a single antiplatelet drug beat aspirin after heart valve replacement?
- Mountain air or heart risk? trial asks if high altitude is safe for aortic stenosis patients.